Statistics

Original breve

Gabapentinoides en indicaciones no autorizadas en la ficha técnica: ¿es necesaria una estrategia de desprescripción?

Off-label use of gabapentinoid drugs: is it necessary a deprescription strategy?

Amaya Echeverría Gorritia,b,

Corresponding author

aecheveg@navarra.es

Autora para correspondencia.

, Natalia Alzueta Istúriza,b, Patricia García Gonzáleza,b, Julen Fernández Gonzáleza,b, Lorea Sanz Álvareza,b, Javier Garjón Parraa,b

a Subdirección de Farmacia y Prestaciones, Servicio Navarro de Salud-Osasunbidea, Pamplona, España

b Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, España

Read

9759

Times
was read the article

1626

Total PDF

8133

Total HTML

Share statistics

Article information

ISSN: 02139111
Original language: Spanish

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 May	62	7	69
2025 April	174	51	225
2025 March	172	36	208
2025 February	197	58	255
2025 January	166	30	196
2024 December	152	46	198
2024 November	172	74	246
2024 October	191	65	256
2024 September	187	47	234
2024 August	278	63	341
2024 July	207	57	264
2024 June	179	54	233
2024 May	212	71	283
2024 April	188	34	222
2024 March	249	51	300
2024 February	179	57	236
2024 January	251	68	319
2023 December	319	58	377
2023 November	2520	206	2726
2023 October	215	70	285
2023 September	121	58	179
2023 August	118	22	140
2023 July	109	42	151
2023 June	95	29	124
2023 May	130	39	169
2023 April	168	60	228
2023 March	559	133	692
2023 February	169	40	209
2023 January	150	0	150
2022 December	244	0	244